000 01107 a2200325 4500
005 20250513142010.0
264 0 _c19980521
008 199805s 0 0 eng d
022 _a0048-5764
040 _aNLM
_beng
_cNLM
100 1 _aWigal, S B
245 0 0 _aReliability and validity of the SKAMP rating scale in a laboratory school setting.
_h[electronic resource]
260 _bPsychopharmacology bulletin
_c1998
300 _a47-53 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAttention Deficit Disorder with Hyperactivity
_xdrug therapy
650 0 4 _aChild
650 0 4 _aDopamine Uptake Inhibitors
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethylphenidate
_xtherapeutic use
650 0 4 _aProspective Studies
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aReproducibility of Results
700 1 _aGupta, S
700 1 _aGuinta, D
700 1 _aSwanson, J M
773 0 _tPsychopharmacology bulletin
_gvol. 34
_gno. 1
_gp. 47-53
999 _c9531269
_d9531269